Aashka Hospitals is a single-location, multi-specialty hospital in Gandhinagar, Gujarat, built from the ground up to deliver advanced surgical and critical care in a city that had little of either. Incorporated in 2012 and listed on the BSE SME Platform in 2021, the company has since operated as a standalone entity with no subsidiaries, channelling everything through one 150-bed facility where the core idea is simple: house super-specialties under one roof and pair them with an in-house pharmacy so the patient never has to go elsewhere. That recurring approach - own the treatment, own the diagnostics, own the medicine counter - explains the entire business.
Business segments
A single engine with two tightly linked revenue streams - a tertiary-care hospital that earns from procedures and room charges, and an in-house pharmacy that fills the prescriptions those procedures generate.
1. The hospital: advanced surgery and intensive care under one roof
A 150-bed facility where nearly half the beds are ICU units, built for the kind of complex procedures that would otherwise require a trip to Ahmedabad.
- Designed around operating theatres, not just wards - the hospital runs six operating theatres: two dedicated to cardiac procedures with class 100 modular environments, and four more each assigned to a distinct super-specialty, all supported by laminar airflow and HEPA filtration. Two additional procedure rooms handle endoscopy and minor interventions, so surgical throughput does not compete with diagnostic caseload.
- Intensive care is the backbone - 65 of the 150 beds are ICU beds, staffed round-the-clock by certified intensivists and nurses, and equipped with intelligent ventilators, biphasic defibrillators, and touch-screen multipara monitors fed by a centralized gas supply. That ratio - roughly 43% ICU beds - signals a hospital built for acuity, not volume.
- Diagnostics feed the surgical pipeline - a flat-panel Cath Lab (financed through a term loan from SREI Equipment Finance, secured against the equipment itself) sits alongside a CT scanner and a pneumatic transfer system, so imaging and intervention happen on the same floor without patient transfer delays.
- The land is the collateral, and the constraint - the entire operation sits on two survey-number plots totalling 3,060 square metres in Village-Sargasan, Gandhinagar, and that property is mortgaged to Bank of India to secure the company’s working capital and term loans. The single-site nature means growth must come from intensity of use, not footprint expansion.
- A captive patient base next door - in January 2024, the hospital was empanelled by Gujarat International Finance Tec-City (GIFT City) to provide healthcare to its staff, giving it a steady stream of corporate patients from the financial hub on its doorstep.
2. The in-house pharmacy: capturing the prescription at the point of care
A pharmacy inside the hospital that converts every discharge summary and outpatient consultation into a retail sale before the patient leaves the building.
- Revenue at the counter - the pharmacy sells pharmaceutical products directly to patients, with revenue recognized at the point of sale, net of returns and taxes. There is no separate distribution channel or wholesale arm; every sale is a walk-in or bedside delivery.
- Stock valued conservatively - inventory is held at the lower of cost and net realizable value using the FIFO method for pharmacy stock, while consumables are valued at cost using the same FIFO method across the hospital. That keeps reported stock close to replacement cost.
- Tied to the hospital’s patient flow - the pharmacy has no standalone storefront or brand outside the hospital premises, meaning its fortunes rise and fall with inpatient admissions and outpatient footfall. It is a capture business, not a destination business.
Group structure and partners
A promoter-led, debt-financed standalone with no subsidiaries - and a history of exploring tie-ups that have not yet changed the single-site reality.
- Tightly held by its founding family - Chairman and Managing Director Bipinchandra D. Shah owns 49.70% of the equity, and together with Aashka Hospitality Private Limited (11.66%), the promoter group holds 61.37%. The company has 229 permanent employees and no foreign operations or earnings.
- Secured lending anchors the balance sheet - Bank of India provides cash credit, term loans, and a working capital term loan, all secured by a charge on plant and machinery, stock and book debts, and an equitable mortgage of the hospital land, plus additional collateral land owned by directors in Dharmoda and Dharisana. SREI Equipment Finance separately financed the Cath Lab, secured primarily by hypothecation of the Cath Lab equipment, with a registered mortgage of commercial land at Mouje-Dharisana as collateral security.
- Related-party ties run through operations - the company has a three-year service contract with Haresh Dineshbhai Shah, brother of the Chairman, effective April 2023, and the Chairman’s daughter was appointed to a place of profit. Enterprises linked to key management include Pyramid Associates and Pryamid Worldwide Pvt Ltd.
- Inorganic ambitions, not yet realized - in FY22, the company advanced roughly ₹28.7 crore to the managing director for purchase of land for a wellness centre, and another ₹28.6 crore to three parties under agreements for acquisition or tie-up with a new hospital. A further ₹8.17 crore was advanced to 14 parties for wellness-centre development. In September 2021, it signed a non-binding MoU with Vaidehi-Backbone Hospital in Rajkot - a 500-bed super-specialty facility with 116 ICU beds and India’s largest PSA-based onsite oxygen plant - for a phased operational integration that would have brought its founder onto Aashka’s board, though the dossier carries no evidence of completion.